Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
2.
Int J Urol ; 23(12): 984-990, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27605411

RESUMEN

OBJECTIVES: To present our experience with a sigmoid orthotopic neobladder. METHODS: We retrospectively evaluated the functional and oncological outcomes of 160 patients who underwent orthotopic neobladder reconstruction using a detubularized 20-25-cm sigmoid segment at our institution. Each patient was evaluated every 3 months the first year, every 6 months for the next 4 years and annually thereafter. Urodynamic studies of all consenting patients were carried out after 6 months, and 2, 5 and 10 years. We carried out the log-rank test, and used Cox regression models and Kaplan-Meier survival analysis. The anova test was used to compare urodynamic findings over time. RESULTS: Mean follow up was 6.8 years (range 0.65-21.7 years). Overall survival was 58.1% at 5 years, and 47.1% at 10 years. Early complications occurred in 36 patients (22.6%); late complications in 40 (25%). Stage V chronic kidney disease developed in two patients (1.3%). Complete (daytime and night-time) continence, defined as no need for pads or condom devices, was achieved by 45% of patients at 5 years, daytime continence was achieved by just 36% of patients; both were unchanged at 10 years. A significant difference emerged in maximal neobladder capacity and post-void residual values between 6 months and 2 years, and between 2 and 5 years (P < 0.01 and P = 0.03, respectively). CONCLUSIONS: Sigmoid neobladder continence and capacity significantly improve over the first 5 years, and they remain stable over the long term. Upper urinary tract function is not affected by endoluminal pressure, and the rate of metabolic imbalance is negligible.


Asunto(s)
Colon Sigmoide/cirugía , Cistectomía , Procedimientos de Cirugía Plástica , Neoplasias de la Vejiga Urinaria/cirugía , Reservorios Urinarios Continentes , Estudios de Seguimiento , Humanos , Estudios Retrospectivos , Resultado del Tratamiento , Urodinámica
3.
J Sex Med ; 10(2): 408-19, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23171237

RESUMEN

INTRODUCTION: Male to female (MtFs) and female to male (FtMs) subjects with gender identity disorder (GID) seem to differ with regard to some sociodemographic and clinical features. Currently, no descriptive studies focusing on MtFs and FtMs attending an Italian clinic are available. AIM: To describe the sociodemographic characteristics of a GID population seeking assistance for gender transition and to assess possible differences in those features between MtFs and FtMs. METHODS: A consecutive series of 198 patients was evaluated for gender dysphoria from July 2008 to May 2011 in four dedicated centers. A total of 140 subjects (mean age 32.6 ± 9.0 years old) meeting the criteria for GID, with their informed consent and without genital reassignment surgery having already been performed, were considered (92 MtFs and 48 FtMs). Diagnosis was based on formal psychiatric classification criteria. MAIN OUTCOME MEASURES: Medical history and sociodemographic characteristics were investigated. Subjects were asked to complete the Body Uneasiness Test (a self-rating scale exploring different areas of body-related psychopathology), Symptom Checklist-90 Revised (a self-rating scale to measure psychological state), and the Bem Sex Role Inventory (a self-rating scale to evaluate gender role). The presence of psychiatric comorbidities was evaluated using the Structured Clinical Interviews for Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) (SCID I and SCID II). RESULTS: Several significant differences were found between MtFs and FtMs regarding lifestyle and sociodemographic factors and in psychometric test scores. No differences were found in terms of psychiatric comorbidity. CONCLUSIONS: This is the first large study reporting the sociodemographic characteristics of a GID sample referring to Italian clinics, and it provides different profiles for MtFs and FtMs. In particular, FtMs display significantly better social functioning.


Asunto(s)
Identidad de Género , Transexualidad/diagnóstico , Transexualidad/epidemiología , Adulto , Comorbilidad , Estudios Transversales , Manual Diagnóstico y Estadístico de los Trastornos Mentales , Femenino , Humanos , Entrevista Psicológica , Italia , Estilo de Vida , Masculino , Trastornos Mentales/diagnóstico , Trastornos Mentales/epidemiología , Trastornos Mentales/psicología , Psicometría/estadística & datos numéricos , Reproducibilidad de los Resultados , Autoevaluación (Psicología) , Procedimientos de Reasignación de Sexo , Conducta Sexual , Factores Socioeconómicos , Encuestas y Cuestionarios , Transexualidad/psicología , Adulto Joven
4.
Appl Immunohistochem Mol Morphol ; 19(5): 478-83, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21558843

RESUMEN

Hepatoid adenocarcinoma is a rare neoplasm, which has a striking morphologic similarity to hepatocarcinoma. It has been described in different organs, the most common are stomach, lung, and pancreas. In some cases, it is characterized by high serum levels of α-fetoprotein. This tumor has a pattern similar to the hepatocarcinoma. The typical features are a combination of histopathologic aspects of solid nests and trabecular structures of polygonal atypical cells with eosinophil and granular cytoplasm and immunohistochemical expression of α-fetoprotein and of carcinoembryonic antigen in half of cases. Here, we report the case of an old female patient affected by hepatoid adenocarcinoma of the ureter with ovarian, small intestine, and hepatic involvement. We discuss the clinical aspects, the morphologic features, and the immunoistochemical staining useful for differential diagnosis.


Asunto(s)
Adenocarcinoma/patología , Carcinoma Hepatocelular/patología , Intestino Delgado/patología , Neoplasias Hepáticas/secundario , Neoplasias Ováricas/secundario , Uréter/patología , Anciano de 80 o más Años , Femenino , Factor de Transcripción GATA3/metabolismo , Humanos , Inmunohistoquímica , Antígeno Lewis X/metabolismo , Neoplasias Hepáticas/patología , Proteínas de la Membrana/metabolismo , Neoplasias Ováricas/patología
5.
Hum Pathol ; 42(8): 1149-58, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21334719

RESUMEN

A plasmacytoid variant of urothelial carcinoma has been recently recognized in the World Health Organization classification system. This is characterized by a discohesive growth of plasmacytoid cells with eccentric nuclei, extending in the bladder wall and often in the perivesical adipose tissue. Herein, we report the clinicopathologic, immunohistochemical, ultrastructural, and molecular features of a series of plasmacytoid urothelial carcinoma of the urinary bladder. Four bladder carcinomas characterized by epithelial cells with morphologic appearance resembling plasma cells were evaluated at the immunohistochemical, electron microscopic, and molecular genetic levels. Tumor cells stained with cytokeratins, epithelial membrane antigen, GATA-3 (endothelial transcription factor 3), CD15, p53, and p16. In addition, malignant cells strongly stained with CD138 in all the cases, whereas leukocyte common antigen and multiple myeloma 1/interferon regulatory factor 4 were completely negative, nor immunoreactivity was seen for either κ or λ light chains. The electron microscopic examination showed the presence of divergent squamous and glandular differentiation. At variance with conventional urothelial carcinoma, the analysis of exons 4-9 of TP53 gene revealed no alteration in all the 4 tumors tested, and this can be of value in choosing additional chemotherapy after surgery. Plasmacytoid carcinoma of the bladder is a tumor entity, which can be characterized by specific immunohistochemical markers, including positivity for GATA-3, and presents phenotypic and genotypic peculiarities.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Carcinoma de Células Transicionales/patología , Células Plasmáticas/ultraestructura , Neoplasias de la Vejiga Urinaria/patología , Anciano , Biomarcadores de Tumor/genética , Carcinoma de Células Transicionales/genética , Carcinoma de Células Transicionales/metabolismo , ADN de Neoplasias/análisis , Femenino , Factor de Transcripción GATA3/genética , Factor de Transcripción GATA3/metabolismo , Humanos , Hibridación in Situ , Masculino , Persona de Mediana Edad , Mutación , Células Plasmáticas/metabolismo , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismo , Neoplasias de la Vejiga Urinaria/genética , Neoplasias de la Vejiga Urinaria/metabolismo
6.
Appl Immunohistochem Mol Morphol ; 18(4): 396-9, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20216403

RESUMEN

Clear cell transitional carcinoma of the bladder is a subtype of transitional carcinoma that morphologically resembles a clear cell renal cell carcinoma. Although kidney tumors do not frequently metastasize to the bladder, the recurrence after a clear cell renal cell carcinoma has been reported even several years after nephrectomy. We report the case of a male patient to whom radical nephrectomy for a clear cell renal cell carcinoma has been done, with a bladder tumor featuring polygonal cells with abundant clear cytoplasm deeply infiltrating the vesical wall. We discuss the morphologic features, the immunohistochemical staining with a new marker and the UroVysion FISH analysis to achieve a definitive diagnosis.


Asunto(s)
Carcinoma de Células Renales/patología , Neoplasias de la Vejiga Urinaria/patología , Neoplasias de la Vejiga Urinaria/secundario , Urotelio/patología , Anciano de 80 o más Años , Biomarcadores de Tumor , Carcinoma de Células Renales/diagnóstico , Diagnóstico Diferencial , Predisposición Genética a la Enfermedad , Humanos , Inmunohistoquímica , Masculino , Neoplasias de la Vejiga Urinaria/diagnóstico
7.
Pathol Oncol Res ; 16(2): 177-9, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19731088

RESUMEN

Primary testicular leiomyosarcoma is an uncommon tumor with only few cases described in literature. In young people this rare tumor seems to be related to radiotherapy and anabolic steroids abuse. In older people there are apparently no risk factors. We describe one further case in a 77-years old man with full histological and ultrastructural evaluation. A short term follow-up of one year signals no recurrence of the disease.


Asunto(s)
Leiomiosarcoma/ultraestructura , Neoplasias Testiculares/ultraestructura , Anciano , Humanos , Leiomiosarcoma/metabolismo , Leiomiosarcoma/cirugía , Masculino , Orquiectomía , Neoplasias Testiculares/metabolismo , Neoplasias Testiculares/cirugía
8.
Int J Urol ; 11(6): 440-4, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15157220

RESUMEN

Primary leiomyosarcomas arising in the penis are rare, with only 29 reported cases to date. We review the published records on this entity and describe an additional case of penile leiomyosarcoma occurring in a 53-year-old patient who underwent postectomy for a firm nodule in the prepuce. Four years later he experienced local recurrence which was successfully treated with partial penectomy.


Asunto(s)
Leiomiosarcoma/patología , Recurrencia Local de Neoplasia/patología , Neoplasias del Pene/patología , Humanos , Leiomiosarcoma/cirugía , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/cirugía , Neoplasias del Pene/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA